Related Experiment Video
Updated: Jun 25, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Detecting Alzheimer's Disease Stages and Frontotemporal Dementia in Time Courses of Resting-State fMRI Data Using a
Mohammad Amin Sadeghi1, Daniel Stevens2, Shinjini Kundu1
1Division of Neuroradiology, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medicine, 600 N Wolfe St, Phipps B100F, Baltimore, MD, 21287, USA.
Accurately diagnosing Alzheimer's disease (AD) and frontotemporal dementia (FTD) is vital. Machine learning models using resting-state fMRI (rs-fMRI) and clinical data can effectively differentiate these conditions and mild cognitive impairment (MCI).
Area of Science:
- Neuroscience
- Medical Imaging
- Artificial Intelligence
Background:
- Distinguishing between neurodegenerative dementia subtypes like Alzheimer's disease (AD) and frontotemporal dementia (FTD) is clinically challenging due to overlapping symptoms and atypical presentations.
- Resting-state functional magnetic resonance imaging (rs-fMRI) reveals condition-specific brain alterations in AD, FTD, and mild cognitive impairment (MCI) compared to healthy controls (HC).
Purpose of the Study:
- To develop and evaluate a machine learning model for accurate classification of AD, FTD, healthy controls (HC), and MCI using rs-fMRI data.
- To assess the impact of integrating clinical variables with imaging data on diagnostic model performance.
Main Methods:
- rs-fMRI data and clinical information were curated from the ADNI and FTLDNI databases.
- Preprocessing, feature extraction, and gradient-boosted decision trees with nested cross-validation were employed to build classification models.
- Model performance was evaluated using balanced accuracy, macro-averaged AUC, and macro-averaged F1 scores on unseen test data.
Main Results:
- A model using only rs-fMRI features achieved 74.4% balanced accuracy, misclassifying AD scans as MCI.
- Integrating clinical variables significantly improved model performance, yielding 91.1% balanced accuracy, 0.99 AUC, and 0.92 F1 score.
- The multimodal model demonstrated high accuracy in classifying FTD (F1=0.99), HC (F1=0.99), MCI (F1=0.86), and notably improved AD classification (F1=0.74).
Conclusions:
- A multimodal machine learning approach combining rs-fMRI and clinical data offers a robust and accurate method for differentiating AD, FTD, MCI, and HC.
- This approach holds significant potential for improving early and precise diagnosis of dementia subtypes, guiding treatment strategies.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....

